Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease mediated by autoantibodies to nicotinic acetylcholine receptors on the post-synaptic side of the neuromuscular junction. It affects the voluntary muscles and characterised by weakness and fatigability.

Muscle weakness, Fatigue, Diplopia (double vision), Ptosis, Difficulty chewing, Difficulty swallowing, Proximal myopathy, Mushy or nasal quality speech, Facial weakness

Autoantibody

Presence of autoimmune disease, Age less than 50 years in female and more than 50 years in male, Thymic hyperplasia or atrophy or tumour

Acetylcholine receptor antibody test, Tensilon test, Electromyography (EMG), CT scan to exclude thymoma

Anticholinesterase, Immunosuppressive therapy, Thymomectomy